Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients. (25th October 2021)

• Record Type: Journal Article
• Authors: de Castilhos, Juliana; Zamir, Eli; Hippchen, Theresa; Rohrbach, Roman; Schmidt, Sabine; Hengler, Silvana; Schumacher, Hanna; Neubauer, Melanie; Kunz, Sabrina; Müller-Esch, Tonia; Hiergeist, Andreas; Gessner, André; Khalid, Dina; Gaiser, Rogier; Cullin, Nyssa; Papagiannarou, Stamatia M; Beuthien-Baumann, Bettina; Krämer, Alwin; Bartenschlager, Ralf; Jäger, Dirk; Müller, Michael; Herth, Felix; Duerschmied, Daniel; Schneider, Jochen; Schmid, Roland M; Eberhardt, Johann F; Khodamoradi, Yascha; Vehreschild, Maria J G T; Teufel, Andreas; Ebert, Matthias P; Hau, Peter; Salzberger, Bernd; Schnitzler, Paul; Poeck, Hendrik; Elinav, Eran; Merle, Uta; Stein-Thoeringer, Christoph K;
• Is Part Of: Clinical infectious diseases. Volume 75:Number 1(2022)
• Page Start: e1063
• Page End: e1071
• Publication Date: 2021-10-25
• Subjects: SARS-CoV-2 -- COVID-19 -- microbiome -- dysbiosis -- machine learning; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciab902
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Background: At the entry site of respiratory virus infections, the oropharyngeal microbiome has been proposed as a major hub integrating viral and host immune signals. Early studies suggested that infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are associated with changes of the upper and lower airway microbiome, and that specific microbial signatures may predict coronavirus disease 2019 (COVID-19) illness. However, the results are not conclusive, as critical illness can drastically alter a patient's microbiome through multiple confounders. Methods: To study oropharyngeal microbiome profiles in SARS-CoV-2 infection, clinical confounders, and prediction models in COVID-19, we performed a multicenter, cross-sectional clinical study analyzing oropharyngeal microbial metagenomes in healthy adults, patients with non-SARS-CoV-2 infections, or with mild, moderate, and severe COVID-19 (n = 322 participants). Results: In contrast to mild infections, patients admitted to a hospital with moderate or severe COVID-19 showed dysbiotic microbial configurations, which were significantly pronounced in patients treated with broad-spectrum antibiotics, receiving invasive mechanical ventilation, or when sampling was performed during prolonged hospitalization. In contrast, specimens collected early after admission allowed us to segregate microbiome features predictive of hospital COVID-19 mortality utilizing machine learning models. Taxonomic signatures were found to perform better than models utilizing clinical variables with Neisseria and Haemophilus species abundances as most important features. Conclusions: In addition to the infection per se, several factors shape the oropharyngeal microbiome of severely affected COVID-19 patients and deserve consideration in the interpretation of the role of the microbiome in severe COVID-19. Nevertheless, we were able to extract microbial features that can help to predict clinical outcomes. Abstract : Coronavirus disease 2019 (COVID-19) infections can affect the architecture of the oropharyngeal microbiome in severe cases. Neisseria or Haemophilus spp. can predict poor outcomes in hospitalized patients, but antibiotic treatments, ventilation, or sampling timepoints are major confounders when considering microbiome features as biomarkers.